Results 91 to 100 of about 1,041 (166)

Drug screens of NGLY1 deficiency in worm and fly models reveal catecholamine, NRF2 and anti-inflammatory-pathway activation as potential clinical approaches

open access: yesDisease Models & Mechanisms, 2019
N-glycanase 1 (NGLY1) deficiency is an ultra-rare and complex monogenic glycosylation disorder that affects fewer than 40 patients globally. NGLY1 deficiency has been studied in model organisms such as yeast, worms, flies and mice.
Sangeetha Iyer   +8 more
doaj   +1 more source

Clone size, O-GlcNAc, and NGLY1 decreased in Png1 or OGT mutant midgut used MARCM clonal system.

open access: yes, 2022
(A) In the midgut of FRT82, Png1ex18; FRT82B, and sxc7; FRT82B flies. (B) The number of clones per field in midguts from the indicated genotype. (C) The number of cells per clone in midguts from the indicated genotype.
Lara K. Abramowitz (1322955)   +2 more
core   +1 more source

Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1

open access: yes, 2018
BACKGROUND: Although NGLY1 is known as a pivotal enzyme that catalyses the deglycosylation of denatured glycoproteins, information regarding the responses of human cancer and normal cells to NGLY1 suppression is limited.
Ho, Yin Ying   +35 more
core   +1 more source

Tissue-specific regulation of BMP signaling by Drosophila N-glycanase 1

open access: yeseLife, 2017
Mutations in the human N-glycanase 1 (NGLY1) cause a rare, multisystem congenital disorder with global developmental delay. However, the mechanisms by which NGLY1 and its homologs regulate embryonic development are not known. Here we show that Drosophila
Antonio Galeone   +5 more
doaj   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Transiently elevated plasma methionine, S‐adenosylmethionine and S‐adenosylhomocysteine: Unreported laboratory findings in a patient with NGLY1 deficiency, a congenital disorder of deglycosylation

open access: yesJIMD Reports, 2019
We report on a 5‐year‐old female born to consanguineous parents, ascertained at the age of 23 months for an elevated plasma methionine level, a mildly abnormal total plasma homocysteine (tHcy), and elevated aminotransferases. She had global developmental
Caitlin A. Chang   +4 more
doaj   +1 more source

Clinical and genetic characterization of patients segregating variants in KPTN, MINPP1, NGLY1, AP4B1, and SON underlying neurodevelopmental disorders:Genetic and phenotypic expansion

open access: yes, 2022
Neurodevelopmental disorders (NDDs) are heterogeneous genetic conditions of the central nervous system (CNS). Primary phenotypes of NDDs include epilepsy, loss of developmental skills, abnormal movements, muscle weakness, ocular anomalies, hearing ...
Hasan Aman   +34 more
core   +1 more source

Orthopaedic phenotyping of NGLY1 deficiency using an international, family-led disease registry

open access: yesOrphanet Journal of Rare Diseases, 2019
Background NGLY1 deficiency is a rare autosomal recessive disorder caused by loss in enzymatic function of NGLY1, a peptide N-glycanase that has been shown to play a role in endoplasmic reticulum associated degradation (ERAD).
Eli M. Cahan, Steven L. Frick
doaj   +1 more source

Suppression of glycosidase NGLY1 induces multifaceted anticancer responses.

open access: yes, 2018
Purpose: NGLY1 is a pivotal enzyme that catalyzes the deglycosylation of denatured glycoproteins and facilitates proteasome-mediated protein degradation.
Lin, Victor   +11 more
core  

Defects in the neuroendocrine axis cause global development delay in aDrosophilamodel of NGLY1 Deficiency

open access: yes, 2018
N-glycanase 1 (NGLY1) Deficiency is a rare monogenic multi-system disorder first described in 2014. NGLY1 is evolutionarily conserved in model organisms, including theDrosophila melanogasterNGLY1 homolog,Pngl.
Joshua D. Mast   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy